Unique ID issued by UMIN | UMIN000044727 |
---|---|
Receipt number | R000051081 |
Scientific Title | Verification study on the effect of food material intake on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study- |
Date of disclosure of the study information | 2021/07/02 |
Last modified on | 2022/05/09 18:32:34 |
Verification study on the effect of food material intake on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study-
Verification study on the effect of food material intake on abdominal visceral fat
Verification study on the effect of food material intake on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study-
Verification study on the effect of food material intake on abdominal visceral fat
Japan |
Not applicable
Not applicable | Adult |
Others
NO
To investigate the safety and efficacy of intake of food material for 12 weeks on abdominal fat area reduction in healthy males and females with BMI 23 kg/m2 or more and less than 30 kg/m2
Safety,Efficacy
Visceral fat area
Body weight,BMI,Waist circumference,hip circumference, W/H ratio,Subcutaneous fat area,total fat area,total cholesterol,LDL- cholesterol,HDL- cholesterol,triglyceride,glucose,HbA1c
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Intake of test food for 12 weeks
Intake of placebo food for 12 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Japanese Males and females aged of 20-64 years
2)Subjects with BMI >=23 kg/m2 and <30 kg/m2
3)Subjects who can visit on schedule days
4)Subjects who recognize the object and contents of the study and submit the written informed consent
1)Subjects who are under treatment or have a history of severe illness in the heart, liver, kidney, digestive organs or other organs
2)Subjects who dyslipidemia, high blood pressure, or diabetes
3)Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study
4)Subjects who regularly use health foods and supplements affecting the study
5)Possible pregnancy, pregnancy and lactation
6)Heavy drinkers
7)Subjects who feel bad mood by blood collect
8)Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period
9)Those who have been diagnosed with chronic constipation
10)Shift worker
11)Subjects who plan business trip or trip for 10 days or more a month
12)Subjects who have allergy related to the test foods
13)Subjects already participating in other clinical trials
14)Subjects who are ineligible due to physician's judgment
90
1st name | Ikuo |
Middle name | |
Last name | Fukuhara |
Fukuhara Clinic
Hospital director
061-1351
3-1-15 Shimamatsuhigashi-machi, Eniwa, Hokkaido, Japan
0123-36-8029
i-feniwa@gray.plala.or.jp
1st name | Tomoya |
Middle name | |
Last name | Yuhki |
New drug research center, Inc.
Clinical Research Dept.
061-1405
452-1 Toiso,Eniwa,Hokkaido,Japan
0123-34-0412
t-yuhki@ndrcenter.co.jp
Maruzen Pharmaceuticals Co., Ltd.
Maruzen Pharmaceuticals Co., Ltd.
Profit organization
Fukuhara Clinic Clinical Trial Review Committee
1-15, Shimamatsuhigashimachi-3-chome, Eniwa-shi, Hokkaido
0123-36-8029
d-kameda@mediffom.co.jp
NO
2021 | Year | 07 | Month | 02 | Day |
Unpublished
Completed
2021 | Year | 06 | Month | 23 | Day |
2021 | Year | 06 | Month | 21 | Day |
2021 | Year | 08 | Month | 17 | Day |
2021 | Year | 11 | Month | 20 | Day |
2021 | Year | 07 | Month | 01 | Day |
2022 | Year | 05 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051081